Sotorasib

Brand name: Lumakras

Rank #413 of 500 drugs by total cost

Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026

$21.3M

Total Cost

Share:

1,188

Total Claims

$21.3M

Total Cost

82

Prescribers

$18K

Cost per Claim

0

Beneficiaries

1,188

30-Day Fills

$259K

Avg Cost/Provider

14

Avg Claims/Provider

Share of Medicare Part D Spending

0.01%

of total Medicare Part D spending

$21.3M of $275.65B

Top Prescribers by Cost

Top 10 prescribers of $21.3M total

🔎 Data Overview

💰

At $17,908 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.

🔍

Average cost of $259,444 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Top Prescribers of Sotorasib

#ProviderSpecialtyLocationClaimsCost
1David SmithHematology-OncologyEaston, MD23$513K
2Fernando SantiniMedical OncologyWest Harrison, NY27$483K
3Shirish GadgeelMedical OncologyDetroit, MI22$479K
4Elizabeth CastronovoNurse PractitionerBoston, MA22$463K
5Mitchell GarrisonHematology-OncologyWenatchee, WA19$427K
6John VillanoHematology-OncologyLexington, KY20$414K
7Katie ZilliNurse PractitionerMilwaukee, WI19$403K
8Kathryn ArbourInternal MedicineNew York, NY20$391K
9Marina Chiara GarassinoHematology-OncologyChicago, IL18$383K
10Manish DhawanHematology-OncologyMinden, LA16$377K
11Kenneth NgMedical OncologyRockville Centre, NY20$374K
12Ying ZengHematology-OncologyDanville, PA20$358K
13Frank FossellaInternal MedicineHouston, TX16$347K
14Harmesh NaikHematology-OncologyDetroit, MI18$343K
15James RooneyHematology-OncologyWorcester, MA19$340K

Top prescribers ranked by total cost for this drug in 2023.

Related Drugs by Cost

#DrugTotal CostClaims
410Teprotumumab-Trbw (Tepezza)$21.4M389
411Nystatin (Nystatin)$21.4M908,177
412Desvenlafaxine Succinate (Desvenlafaxine Succinate Er)$21.3M257,580
413Sotorasib (Lumakras)$21.3M1,188
414Ibuprofen (Ibuprofen)$21.2M2,537,634
415Lubiprostone (Lubiprostone)$21.1M86,987
416Omega-3 Acid Ethyl Esters (Omega-3 Acid Ethyl Esters)$21.0M239,899

Related Analysis

Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology